focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Noticed that too. Makes the earlier rise of 14% null and void since it started from a base of -14% on Friday evening. The trade charts look unpromising, many more sells than buys.
Precipitous fall in SP today after an auspicious rise in the last couple of weeks. Was surprised to see the rise on no tangible news but more intrigued to see the fall today on an equal lack of information. Frustrating. Need a trading update.
Total of over £200,000 bought by 4 of IDH directors. Already up over 10% today. Hoping this rise marks the beginning of a sustainable recovery after a major loss of confidence in the last month.
Wish I had had the forethought to download the previous couple of years charts for Kiotech. Now there are nocharts, no moving averages, no technical analysis no directors's deals, no history of the company at all for retail investors. I for one find these useful tools for when to time buying shares. Still seeking buying opportunities at an ask price below 80 pence.
13.7%
Well if you believe LSE Kiotech has not only changed its name but also its board of directors! They are South African, deal in rands, but have neither bought nor sold since August 2009. Come on LSE and get your act together!!!
The name change also seems pretty naf to me. Maybe it will help to keep the company profile in the news. What is really killing this for me is the illiquidity and the spread.
RNS Number : 3274S Corin Group PLC 18 November 2011  18 November 2011 Corin Group PLC Interim Management Statement Corin Group PLC (LSE: CRG, "Corin" or "the Group"), a leading manufacturer and supplier of orthopaedic devices, is today publishing an Interim Management Statement for the period from 1 July 2011 to 17 November 2011. In the four months ended 31 October 2011, underlying constant currency sales growth (excluding the Group's discontinued Chinese operations) has increased to 7%, compared to the 1% level achieved in the first half of the financial year. Many of the major trends noted at the time of the interim results in August have continued. Sales of the Group's hip products have continued to be very strong. The positive impact of initial stocking orders for Mako has outweighed the decline in metal-on-metal ("MoM") hip sales. There has been strong growth in sales of our new hip products in all of the group's geographies where they are approved for sale. Knee sales in the four months ended 31 October continued to decline, but at a slightly slower rate than in the first half. The new Unity knee product continues to make good progress in development, with initial evaluation surgeries now expected within the next three months. As anticipated at the time of the interim results, LARS sales have declined, in comparison to an extremely strong performance in the comparative period, primarily owing to the ongoing clinical debate in Australia regarding the range of indications in anterior cruciate ligament ("ACL") injury that are suitable for repair using LARS. The strongest geographical sales performance was in the USA. Growth in this market is being driven both by sales to Mako, whose hip application is presently being rolled out in the US, and by sales by the Group's small but growing direct sales operation, which is now distributing Cormet following the termination of the distribution agreement with Stryker in July. This strong performance has been tempered by weakness in Australia and certain non-European distributor markets. Corin expects to publish its results for the year ending 31 December 2011 early in March 2012. Peter Huntley, Corin's Chief Executive, commented "The rebalancing of our portfolio away from MoM continues to deliver results. The level of growth across our new hip portfolio is very encouraging and is now outweighing the decline in MoM sales. We are especially encouraged by the progress in the US." Enquiries: Corin Group PLC Peter Huntley, Chief Executive Michael Roller, Finance Director 01285 659 866 College Hill Adrian Duffield/Rozi Morris 020 7457 2020 This information is provide
Looks like it was tipped as buy in Investors Chronicle over the weekend.
Kio was in the top risers today. Tried to take some profit when the buy/sell was at 98/97 but was told I could only sell 1000 shares. Anyone know the reason for this sudden rise?
Well at least this looks like the real thing! Kiotech International plc ("the Company") announces that it has been notified of the following transaction in the Company's ordinary shares of 23p each. On 6 October 2011 Karen Prior, Group Finance Director purchased 10,220 Ordinary shares of 23p each, at a price of 80p per share. Following the purchase Mrs. Prior's shareholding in the Company is 20,000 Ordinary Shares representing 0.11% of the issued share capital. For more information, please contact: Kiotech International plc Richard Edwards, Chief Executive Officer +44 (0)777 641 7129 Karen Prior, Group Finance Director +44 (0)1909 537380
Topped up at 75.5. Decided that since there has been no material change in Kio's financial outlook then this current dip is due to a combination of panic selling and the usual retrace that follows each trading update. Excellent results, and a decent dividend paid. Now let us know how we can achieve greater value through judicious acquisitions to further build on the success achieved through the integration of Optivite.
Thanks for this. So it will not show up as a director's deal then? I guess there must be money in it for the directors. Let's hope there might be some value in it for us too! Anyone looking at the sell trades today though might panic and sell. Mind you that might not be too awful if it creates an opportunity to buy sub 80 pence once more!
I don't understand what happened yesterday. Looks like 3 directors bought at massive discount. Showing up here as disposal of getting on for half a million quid? Does this represent a dilution? Can anyone explain in simple English?
Kio was in the top ten risers this morning on the trading update, Looking good, I expected there to more profit taking,but with a spread like this (11%) its not hard to see why that did not happen.
Topped up a few weeks ago at 82.5 and watching for a big dip to get in at below 80p. Lots of selling on here the last month or two. I guess folks are getting impatient since the last results looked so promising and yet here we are again in the doldrums. Hoping for some positive news regarding expected aquisitions and how this is likely to boost sales.
When is the dividend due? Shame the good news in the final results has had little effect. Any gains were made in the month previous to the final results when the trading update was published. No further news on the acquisitions Kio want to make? Still money in the bank after the purchase of new premises last year. Any news would be welcome following the latest slide in SP.
Seems Amati are buying in once more. The Company (Kiotech) was notified on 22 February 2011 that following an acquisition of ordinary shares, Amati Global Investors, through its funds, Amati VCT plc, ViCTory VCT plc and Amati VCT 2 plc, is interested in an aggregate of 2,457,061 ordinary shares (representing 13.6% of the total voting rights of the Company. Still looking for buying opportunities before the results come out in April. Somewhere in the region of 80 to 85 pence would suit me,
Corin expects to publish its results early in March, Does anyone know (or care) what is the cause of the volatility today,and of the general fall in the SP over the last few months? Can find no news about Corin since the last trading update which was mid November 2010,
Has the recent rise been in anticipation of the finalisation of the Bupa aquisition? In which case do we expect a levelling out or a fall now until the next aquisition? Hope there are no more cash calls or consolidations in view. Have to confess I am nervous as hell being a shareholder in this company!